ESMO 25: Biokin/SystImmune’s BsADC Doubles ORR/PFS Vs Chemo In NPC

Consistent Efficacy Seen In The Global Phase I

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.